TO

Takeshi Ogoshi

Director Director DIN 00579073
DIN 00579073 First appointment Aug 2008 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Aug 2008
Shareholding value β€’β€’β€’β€’ Premium profile

About Takeshi Ogoshi

Data last updated:

Takeshi Ogoshi was a Director at Eisai Pharmaceuticals India Private Limited (2008–2010) and Director at Eisai#1 Pharmaceuticals India Private Limited (from 2008). The companies operate in Pharma.

DIN 00579073
Primary Designation Director
Industry Pharma
First Appointment 07 Aug 2008
Oldest Company Age 22 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Aug 20082007₹402 Cr (FY 2025)Active
Director07 Aug 20082004Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Eisai#1 Pharmaceuticals India Private Limited
Eisai Pharmaceuticals India Private Limited
Premium access

Shareholding and investment profile for Takeshi Ogoshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Takeshi Ogoshi

Takeshi Ogoshi was first appointed on 07 Aug 2008 as Director at Eisai#1 Pharmaceuticals India Private Limited.

Takeshi Ogoshi held 2 earlier board appointments: Eisai Pharmaceuticals India Private Limited (Director, 08 Aug 2008 to 17 Aug 2010); Eisai#1 Pharmaceuticals India Private Limited (Director, from 07 Aug 2008).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available